Abstract: A compression ignition engine uses two or more fuel charges having two or more reactivities to control the timing and duration of combustion. In a preferred implementation, a lower-reactivity fuel charge is injected or otherwise introduced into the combustion chamber, preferably sufficiently early that it becomes at least substantially homogeneously dispersed within the chamber before a subsequent injection is made. One or more subsequent injections of higher-reactivity fuel charges are then made, and these preferably distribute the higher-reactivity matter within the lower-reactivity chamber space such that combustion begins in the higher-reactivity regions, and with the lower-reactivity regions following thereafter.

Abstract: The present invention provides transgenic, large non-human animal models of diseases and conditions, as well as methods of making and using such animal models in the identification and characterization of therapies for the diseases and conditions.

Abstract: A system, method and computer program product creates an index based on accounting data, or a portfolio of financial objects based on the index where the portfolio is weighted according to accounting data. Indexes may be built with metrics other than market capitalization weighting, price weighting or equal weighting. Financial and non-financial metrics may be used to build indexes to create passive investment systems. A combination of financial non-market capitalization metrics may be used with non-financial metrics to create passive investment systems. Once built, the index may be used as a basis to purchase securities for a portfolio. Specifically excluded are widely-used capitalization-weighted and price-weighted indexes, in which price of a security contributes in a substantial way to calculation of weight of that security in the index or the portfolio, and equal weighting weighted indexes. The indexes may be constructed to minimize volatility.

Abstract: Consistent handover can be provided between a plurality of objects by providing handover mode control information defining an object for initiating handover from among at least one object in a system environment including the at least one object, wherein the at least one object is able to initiate handover between heterogeneous networks.

Abstract: A natural input image is upscaled, first by interpolation. Second, edges in the interpolated image are sharpened by a lion-parametric patch transform. The result is decomposed into an edge layer and a detail layer. Only pixels in the detail layer enhanced, and the enhanced detail layer is merged with the edge layer to produce a high resolution version of the input image.

Abstract: An apparatus includes a sensor array with a plurality of active pixels. Each active pixel in the sensor array includes: a three transistor (3T) sensor with a source follower transistor, and a detection diode coupled in series to a parasitic capacitor at a sensing junction. A gate of the source follower transistor amplifier is coupled to the sensing junction. The apparatus includes an insulator layer over the sensor array. The insulator layer provides a variable capacitance to the sensing junctions of underlying active pixels in response to portions of an object being proximate to the insulator layer. The variable capacitance is used to detect an image of the object.

Abstract: A pulse generator is provided. The pulse generator includes: a time delayed pulse generation unit including a plurality of delay cells for receiving a first pulse having a first pulse width and outputting pulses delayed by a particular time delay value on the basis of one of a rising edge and a falling edge of the first pulse; an edge combiner configured to receive the plurality of time delayed pulses from the time delayed pulse generation unit and generate second pulses having a second pulse width; and a channel selector configured to regulate the number of outputs of the second pulses generated by the edge combiner.

Abstract: An exemplary method for configuring an intelligent electronic device in a power delivery system includes receiving identification data for the intelligent electronic device, based on the received identification data and on capabilities of the intelligent electronic device, generating a configuration profile for the intelligent electronic device, receiving operating parameters for the intelligent electronic device, determining a coordination of the intelligent electronic device with the power delivery system based on the received operating parameters, displaying the determined coordination, modifying the configuration profile based on the received operating parameters and the determined coordination, and configuring the intelligent electronic device with the modified configuration profile.

Abstract: Provided is a method and system for estimating a channel in a wireless communication system. An interference coefficient is calculated based on a known structure of a pilot, and a channel value in a frequency domain is estimated. A channel value in a time domain is obtained by transforming the channel value in the frequency domain and the channel delay values are subtracted from the channel value in the time domain, thereby cancelling interference.

Abstract: An operation control method in a base station of a wireless communication system includes: checking whether or not an allowed mobile station exists in coverage of the base station and overall coverage of base stations adjacent to the base station; and controlling the base station to perform transmission/reception at a predetermined period through a first discontinuous operation, when the allowed mobile station does not exist in the coverage of the base station and the overall coverage of the adjacent base stations.

Abstract: The deposit formation resistance performance of turbine oils containing amine antioxidants and antiwear additives is enhanced beyond the level of that of turbine oils containing tricresyl phosphate antiwear additive by employing as the antiwear additive a 4,4?-(Isopropylidenediphenyl)bis(diphenyl phosphate).

Abstract: The present invention relates to an isolated DNA molecule encoding a fagopyritol synthase. A method for producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor is also described. The method includes providing a fagopyritol synthase, providing a substrate comprising a galactosyl donor and a galactosyl acceptor, and combining the fagopyritol synthase with the substrate under conditions effective produce a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor.

Abstract: There is disclosed a medical needle comprising a needle shaft that defines a longitudinal axis, a tip formed at one end of the shaft, and an ultrasonic reflector formed in an outer surface of the needle shaft. The reflector comprises a first reflector surface that is at an angle of no more than 35° to the longitudinal axis of the shaft and that faces towards the tip, and at least one additional reflector surface that forms an angle to the first reflector surface within the range of 75° to 105°, and that is substantially concave in a direction towards the first reflector surface.

Abstract: The present invention is a method for synchronizing multiple layers of constrained optimization with both layers having some common variables in a to processing plant. The layers of optimization can include Planning, Scheduling, Real-Time Optimization and Model Predictive Control.

Abstract: The invention relates to a method of treatment or prophylaxis of demyelinating disease, in particular the neurodegenerative phase of demyelinating disease, which comprises administration of an acid sensing ion channel (ASIC) antagonist. The invention also relates to a pharmaceutical composition comprising an ASIC antagonist in combination with an additional therapeutic agent, in particular an anti-inflammatory or immunmodulatory agent.

Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain tricyclic compounds (referred to herein as TC compounds), and especially certain 9H-pyrimido[4,5-b]indole, 9H-pyrido[4?,3?:4,5]pyrrolo[2,3-d]pyridine, and 9H-1,3,6,9-tetraaza-fluorene compounds, which, inter alia, inhibit Checkpoint Kinase 1 (CHK1) kinase function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1, that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or II inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or TS inhibitor; (d) a microtubule targeted agent; and (e) ionising radiation.

Abstract: Hematopoietic stem cells and methods for ex vivo expansion of hematopoietic stem cells are provided. The methods comprise culturing the cells in a media containing an effective amount insulin-like growth factor(IGF), fibroblast growth factor (FGF), thrombopoietin (TPO), and stem cell factor (SCF), under conditions sufficient for expansion of said cells. Methods for identifying expanded hematopoeitc stem cells and kits for ex vivo expansion of hematopoietic stem cells are also provided.

Abstract: The present invention relates generally to compounds providing antibacterial therapeutic agents and preparations, and related methods of using and making antibacterial compounds. Antibacterial compounds of the present invention include chalcone, alkylpyrimidine, aminopyrimidine and cyanopyridine compounds and derivatives thereof exhibiting minimum inhibitory concentrations (MIC) similar to or less than conventional antibacterial compounds in wide use. For example, the present invention provides chalcone and cyanopyridine compounds, and derivatives thereof, exhibiting high antibacterial activities having multiple electron withdrawing group substituents, such as halogens and fluorinated alkyl groups, and optionally having hydroxyl and/or alkoxyl groups substituents.

Abstract: A transmitter comprises a first spreading unit configured to multiply each of multiple data symbols with a first spreading code sequence of a first spreading factor; a compression and repetition unit configured to compress output signals of the first spreading unit in time domain and repeat the compressed signal L times (where L is a natural number greater than or equal to 2); a phase modulation unit configured to multiply the compressed and repeated signal with a user dependent phase and output a data block consisting of L sub-blocks; a second spreading unit configured to replicate the data block according to a second spreading factor and multiply each set of the replicated sub-blocks with a second spreading code sequence of the second spreading factor to produce a two-dimensionally spread signal; and a wireless transmission unit configured to transmit the two-dimensionally spread signal using a single-carrier transmission scheme.

Abstract: A call setup method is provided for a MVPN which includes at least one access point apparatus, at least one database, and a plurality of users. The database records a private extension number, a user phone number, and a user identity module of each user and a link address of the corresponding access point apparatus. The access point apparatus corresponding to a MO user receives a call setup request message for setting up a call with a MT user from the MO user. The access point apparatus corresponding to the MO user determines whether the link address of the access point apparatus corresponding to the MT user is valid according to the database. If the link address of the access point apparatus corresponding to the MT user is valid, the MO user and the MT user set up the call through the access point apparatuses corresponding to the link addresses.